BIZTRAC BETA
Other non-specialised retail sale

PHARMASENSE AS

Org. no. 827142352 Limited company (AS) Lillestrøm Incorporated 2021 Active
Ownership graph ↗
Revenue 2024 NOK 3.8m
Operating profit NOK 586,000
Equity NOK −6.3m
Incorporated 2021
Share capital NOK 30,000

Signals

1 flags
  • Negativ egenkapital 2024 Bokført egenkapital er negativ (−6,3 mill kr).

PHARMASENSE AS is registered as a limited company in Lillestrøm, Akershus with organisation number 827142352. The business is classified under other non-specialised retail sale (NACE 47.120). The company was incorporated in 2021. Registered share capital is NOK 30,000, divided into 1000 shares. The company's stated purpose is: “Postordre-/internetthandel med bredt vareutvalg.”. The most recent filed accounts, for the 2024 financial year, show NOK 3.8m in revenue and NOK 586,000 in operating profit.

Key figures · 2024

Revenue
NOK 3.8m
Operating profit
NOK 586,000
Equity
NOK −6.3m
Est. value
NOK 2.4m

Financial health · 2024

Liquidity
0.42
Not satisfactory
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
-136.8%
Weak
Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns PHARMASENSE AS?

SCANDIC INV AS
PHARMASENSE AS
NOK 3.8m rev. · NOK 586,000 profit

PHARMASENSE AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about PHARMASENSE AS

Who owns PHARMASENSE AS?

SCANDIC INV AS is the largest registered owner, with 100.0%.

What is the revenue of PHARMASENSE AS?

PHARMASENSE AS had revenue of NOK 3.8m in 2024.

Who is the general manager of PHARMASENSE AS?

Maher Ayman Salameh is registered as general manager of PHARMASENSE AS.

Where is PHARMASENSE AS based?

PHARMASENSE AS has its business address in Skedsmokorset.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.